|
|
US 7,572,935 B2 |
|
| Modified release formulations of a bupropion salt |
| Werner Oberegger, Mississauga (Canada); Paul Maes, Toronto (Canada); Stefano Turchetta, Rome (Italy); Pietro Massardo, Rome (Italy); and Mohammad Ashty Saleh, Oakville (Canada) |
| Assigned to Biovail Laboratories International S.R.L., St. Michael (Barbados) |
| Filed on Jun. 14, 2007, as Appl. No. 11/762,840. |
| Application 11/762840 is a continuation of application No. 11/751768, filed on May 22, 2007. |
| Application 11/751768 is a continuation of application No. 11/475252, filed on Jun. 27, 2006, granted, now 7,241,805. |
| Claims priority of provisional application 60/693906, filed on Jun. 27, 2005. |
| Prior Publication US 2008/0033043 A1, Feb. 07, 2008 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07C 63/08 (2006.01); C07C 49/80 (2006.01); C07C 225/10 (2006.01); A61K 31/136 (2006.01)
|
